Literature DB >> 8985835

Clinicopathological significance of intestinal and diffuse types of gastric carcinoma in Taiwan Chinese.

C W Wu1, S H Tsay, M C Hsieh, S S Lo, W Y Lui, F K P'eng.   

Abstract

The present study sought to evaluate the clinicopathological features of our gastric cancer patients in terms of a modified Lauren's histological classification and compared the results with those from studies from Japan and Western countries. A total of 536 consecutive patients with gastric cancer were treated surgically between December 1987 and December 1993. A clinicopathological analysis was only performed for intestinal types (IT) and diffuse types (DT) of gastric cancer because patients falling into the 'other' category were too small to produce meaningful data. Of 536 cases of gastric cancer, 268 (50%) were IT, 231 (43.1%) were DT and 37 (6.9%) were of the other type. The overall IT:DT ratio was 1.2. Gastric cancer patients with IT (in contrast to DT) were characterized by older age, male dominance, smaller tumours, the tumour often being located in the lower and upper third of the stomach and less peritoneal metastasis. In both sexes, the peak incidence of gastric cancer patients was in the age group 65-74 years. Men had higher proportions of IT carcinoma than women. The IT:DT ratio for men and women was 1.4 and 0.4, respectively. Although the increased ratio of IT:DT paralleled the advance of age in both sexes, the transitional age (the age at which the IT:DT ratio exceeds 1.0) in male patients (age group 51-64 years) was earlier than for female patients (age group 65-74 years). Patients with IT gastric cancer had a significantly better survival rate than those with DT. However, the type of carcinoma (IT or DT) was not an independent predictor of survival. These data indicate that gastric cancer in Taiwan Chinese has different biological behaviour in terms of IT and DT. The clinicopathological features in IT and DT carcinoma are similar to studies from Japan and from Western countries.

Entities:  

Mesh:

Year:  1996        PMID: 8985835     DOI: 10.1111/j.1440-1746.1996.tb00041.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Prognostic indicators for survival after curative resection for patients with carcinoma of the stomach.

Authors:  C W Wu; M C Hsieh; S S Lo; S H Tsay; A F Li; W Y Lui; F K P'eng
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

2.  Clinicopathologic and molecular features associated with patient age in gastric cancer.

Authors:  Ji Yeon Seo; Eun Hyo Jin; Hyun Jin Jo; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim; Hyun Chae Jung; Dong Ho Lee
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

3.  Human gastric cancer kinase profile and prognostic significance of MKK4 kinase.

Authors:  C W Wu; A F Li; C W Chi; C L Huang; K H Shen; W Y Liu; W Lin
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

4.  The correlation between gastric cancer screening method and the clinicopathologic features of gastric cancer.

Authors:  Ji-Youn Han; Hyehyun Son; Won Chul Lee; Byung Gil Choi
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

5.  Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India.

Authors:  Sajjad Karim; Arif Ali
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

6.  Gastric malignancies in Northern Jordan with special emphasis on descriptive epidemiology.

Authors:  Kamal-E Bani-Hani; Rami-J Yaghan; Hussein-A Heis; Nawaf-J Shatnawi; Ismail-I Matalka; Amjad-M Bani-Hani; Kamal-A Gharaibeh
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

Review 7.  Regulation of sex hormone receptors in sexual dimorphism of human cancers.

Authors:  Daoshan Zheng; Cecilia Williams; Jeremy A Vold; Justin H Nguyen; Denise M Harnois; Sanjay P Bagaria; Sarah A McLaughlin; Zhaoyu Li
Journal:  Cancer Lett       Date:  2018-09-14       Impact factor: 8.679

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.